Chong Hak Chae

703 total citations
48 papers, 582 citations indexed

About

Chong Hak Chae is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Chong Hak Chae has authored 48 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Chong Hak Chae's work include Cancer therapeutics and mechanisms (8 papers), Computational Drug Discovery Methods (8 papers) and Quinazolinone synthesis and applications (7 papers). Chong Hak Chae is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Computational Drug Discovery Methods (8 papers) and Quinazolinone synthesis and applications (7 papers). Chong Hak Chae collaborates with scholars based in South Korea, United States and Yemen. Chong Hak Chae's co-authors include Whanchul Shin, Joo Yun Lee, Sung‐Eun Yoo, Hojoong Kwak, Sunwoo Kim, Mi-Ra Lee, Eunhye Kim, Hye Youn Sung, Woong‐Yang Park and Kwang‐Ho Lee and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Computational Chemistry.

In The Last Decade

Chong Hak Chae

44 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong Hak Chae South Korea 14 347 113 106 65 65 48 582
Yongqi Zhen China 15 400 1.2× 107 0.9× 106 1.0× 41 0.6× 61 0.9× 30 691
Tzu‐Wen Lien Taiwan 12 341 1.0× 101 0.9× 114 1.1× 46 0.7× 72 1.1× 17 644
Mohammed I. El–Gamal United Arab Emirates 15 318 0.9× 227 2.0× 93 0.9× 27 0.4× 41 0.6× 37 609
Zhi Tan United States 15 488 1.4× 45 0.4× 103 1.0× 53 0.8× 121 1.9× 25 779
Long G. Wang United States 10 465 1.3× 113 1.0× 244 2.3× 136 2.1× 73 1.1× 11 761
Meiyang Xi China 15 534 1.5× 189 1.7× 113 1.1× 29 0.4× 27 0.4× 29 745
Tony Eight Lin Taiwan 18 644 1.9× 175 1.5× 220 2.1× 46 0.7× 45 0.7× 60 881
Haiwei Xu China 12 266 0.8× 76 0.7× 127 1.2× 26 0.4× 42 0.6× 27 518
Qianbin Li China 18 467 1.3× 295 2.6× 157 1.5× 135 2.1× 63 1.0× 66 886
Kenichiro Doi Japan 15 560 1.6× 181 1.6× 160 1.5× 29 0.4× 76 1.2× 36 791

Countries citing papers authored by Chong Hak Chae

Since Specialization
Citations

This map shows the geographic impact of Chong Hak Chae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Hak Chae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Hak Chae more than expected).

Fields of papers citing papers by Chong Hak Chae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Hak Chae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Hak Chae. The network helps show where Chong Hak Chae may publish in the future.

Co-authorship network of co-authors of Chong Hak Chae

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Hak Chae. A scholar is included among the top collaborators of Chong Hak Chae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Hak Chae. Chong Hak Chae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yonghyo, et al.. (2025). Discovery of novel benzosultam CRBN ligands. Bulletin of the Korean Chemical Society. 46(1). 48–56.
2.
Park, Chaewon, Il Hwan Kim, Gildon Choi, et al.. (2025). Discovery of BBT-176 as a fourth-generation EGFR tyrosine kinase inhibitor. Results in Chemistry. 16. 102406–102406.
3.
Kim, Eun Hye, et al.. (2024). Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation. PLoS ONE. 19(6). e0305261–e0305261. 3 indexed citations
4.
Yun, Mi Ran, et al.. (2024). Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2). Bulletin of the Korean Chemical Society. 45(7). 639–644. 1 indexed citations
5.
Choi, Jiae, Hee‐Jong Lim, Chong Hak Chae, et al.. (2024). Inhibitors of acetohydroxyacid synthase as promising agents against non-tuberculous mycobacterial diseases. The Journal of Antibiotics. 78(3). 181–189. 2 indexed citations
6.
Ali, Imran, Hyung Jin, Chong Hak Chae, et al.. (2023). DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. European Journal of Medicinal Chemistry. 265. 116052–116052. 7 indexed citations
7.
Lee, Yujin, Mi Ran Yun, Gildon Choi, et al.. (2022). Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis. Bioorganic & Medicinal Chemistry Letters. 75. 128956–128956. 13 indexed citations
8.
Hong, Hyowon, Hee‐Jong Lim, Ji Hye Choi, et al.. (2022). A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway. Acta Pharmaceutica Sinica B. 13(3). 1093–1109. 27 indexed citations
9.
Kim, Yeji, Eok Kyun Lee, Chong Hak Chae, et al.. (2021). Rotational Variance‐Based Data Augmentation in 3D Graph Convolutional Network. Chemistry - An Asian Journal. 16(18). 2610–2613. 3 indexed citations
10.
Park, Sung Bum, et al.. (2019). Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene. Bioorganic & Medicinal Chemistry Letters. 30(1). 126756–126756. 13 indexed citations
11.
Youn, Ui Joung, Joo Yun Lee, Ah‐Reum Han, et al.. (2015). Identification of new pyrrole alkaloids from the fruits of Lycium chinense. Archives of Pharmacal Research. 39(3). 321–327. 16 indexed citations
12.
Park, Chi-Min, Joo Yun Lee, Jae Du Ha, et al.. (2015). Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors. Bioorganic & Medicinal Chemistry. 24(2). 207–219. 11 indexed citations
13.
Lee, Hyeon Ji, Muhammad Latif, Imran Ali, et al.. (2014). ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment. Archives of Pharmacal Research. 37(9). 1130–1138. 11 indexed citations
14.
Shin, Dae‐Seop, Hyang‐Ae Lee, Joo Yun Lee, et al.. (2014). A novel assessment of nefazodone-induced hERG inhibition by electrophysiological and stereochemical method. Toxicology and Applied Pharmacology. 274(3). 361–371. 7 indexed citations
15.
16.
Cho, Sung Yun, Byung Ho Lee, Heejung Jung, et al.. (2013). Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6711–6716. 17 indexed citations
17.
Jung, Suk‐Kyeong, Youngkyung Ko, Joo Hee Kim, et al.. (2012). Identification of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4-one derivatives as inhibitors of the phosphatase SerB653 in Porphyromonas gingivalis, implicated in periodontitis. Bioorganic & Medicinal Chemistry Letters. 22(5). 2084–2088. 8 indexed citations
18.
Chae, Chong Hak, et al.. (2009). Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent. Bioorganic & Medicinal Chemistry. 17(17). 6213–6217. 31 indexed citations
19.
Kang, Nam Sook, Jin Hee Ahn, Sung Soo Kim, Chong Hak Chae, & Sung‐Eun Yoo. (2007). Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(13). 3716–3721. 22 indexed citations
20.
Kim, Hye Jung, et al.. (2004). Computational studies of COX-2 inhibitors: 3D-QSAR and docking. Bioorganic & Medicinal Chemistry. 12(7). 1629–1641. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongqi Zhen Breakdown of academic impact, for papers by Tzu‐Wen Lien Breakdown of academic impact, for papers by Mohammed I. El–Gamal Breakdown of academic impact, for papers by Zhi Tan Breakdown of academic impact, for papers by Long G. Wang Breakdown of academic impact, for papers by Meiyang Xi Breakdown of academic impact, for papers by Tony Eight Lin Breakdown of academic impact, for papers by Haiwei Xu Breakdown of academic impact, for papers by Qianbin Li Breakdown of academic impact, for papers by Kenichiro Doi
Rankless by CCL
2026